AU2003235395A1 - Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water - Google Patents
Pharmaceutical preparation improved in dissolving property of drug slightly soluble in waterInfo
- Publication number
- AU2003235395A1 AU2003235395A1 AU2003235395A AU2003235395A AU2003235395A1 AU 2003235395 A1 AU2003235395 A1 AU 2003235395A1 AU 2003235395 A AU2003235395 A AU 2003235395A AU 2003235395 A AU2003235395 A AU 2003235395A AU 2003235395 A1 AU2003235395 A1 AU 2003235395A1
- Authority
- AU
- Australia
- Prior art keywords
- water
- pharmaceutical preparation
- slightly soluble
- dissolving property
- preparation improved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-147113 | 2002-05-22 | ||
JP2002147113 | 2002-05-22 | ||
PCT/JP2003/006346 WO2003097102A1 (en) | 2002-05-22 | 2003-05-21 | Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003235395A1 true AU2003235395A1 (en) | 2003-12-02 |
Family
ID=29545163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003235395A Abandoned AU2003235395A1 (en) | 2002-05-22 | 2003-05-21 | Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water |
Country Status (4)
Country | Link |
---|---|
JP (2) | JP4743684B2 (en) |
AU (1) | AU2003235395A1 (en) |
TW (1) | TW200306868A (en) |
WO (1) | WO2003097102A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003235395A1 (en) * | 2002-05-22 | 2003-12-02 | Shionogi And Co., Ltd. | Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water |
US8168228B2 (en) * | 2003-10-17 | 2012-05-01 | Sandoz Ag | Antibiotic clarithromycin micropellet compositions |
WO2006115285A1 (en) * | 2005-04-21 | 2006-11-02 | Takeda Pharmaceutical Company Limited | Pharmaceutical composition |
JP2008230967A (en) * | 2005-06-23 | 2008-10-02 | Kowa Co | Pharmaceutical composition |
KR20080071557A (en) * | 2005-11-24 | 2008-08-04 | 오노 야꾸힝 고교 가부시키가이샤 | Solid pharmaceutical preparation and pharmaceutical preparation composition |
MX2009010474A (en) * | 2007-03-29 | 2009-10-19 | Daiichi Sankyo Co Ltd | Pharmaceutical composition. |
CN102481248B (en) * | 2009-04-30 | 2013-12-11 | 武田药品工业株式会社 | Solid preparation |
CA2793525C (en) | 2010-03-19 | 2014-05-06 | Daiichi Sankyo Company, Limited | Method for improving dissolution of anticoagulant agent |
JPWO2013022059A1 (en) | 2011-08-10 | 2015-03-05 | 第一三共株式会社 | Pharmaceutical composition containing diamine derivative |
JP6411265B2 (en) * | 2015-03-30 | 2018-10-24 | 共和薬品工業株式会社 | Entacapone-containing pharmaceutical composition |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3006901B2 (en) * | 1991-03-29 | 2000-02-07 | 塩野義製薬株式会社 | Coated preparation |
JPH0717866A (en) * | 1993-06-16 | 1995-01-20 | Meiji Seika Kaisha Ltd | Medicinal composition |
AR004014A1 (en) * | 1995-10-13 | 1998-09-30 | Meiji Seika Kaisha | AN ANTIBACTERIAL COMPOSITION OF CEFDITOREN PIVOXILO FOR ORAL ADMINISTRATION AND METHOD TO OBTAIN SUCH COMPOSITION |
JPH09309829A (en) * | 1996-05-22 | 1997-12-02 | Taiyo Yakuhin Kogyo Kk | Oral administration preparation containing nitrendipine and its production |
JPH10147524A (en) * | 1996-09-20 | 1998-06-02 | Nippon Kayaku Co Ltd | Forskolin derivative-containing oral preparation and production of medicine preparation |
JP3770518B2 (en) * | 1997-03-28 | 2006-04-26 | エーザイ株式会社 | Oral drugs concealing bitterness |
KR100693266B1 (en) * | 1997-03-28 | 2007-03-27 | 에자이 가부시키가이샤 | Oral pharmaceutical preparations decreased in bitterness by masking |
US6080427A (en) * | 1997-04-17 | 2000-06-27 | Bristol-Myers Squibb Company | Cefadroxil monohydrate tablet formulation |
JP4117811B2 (en) * | 1997-04-22 | 2008-07-16 | 日本化薬株式会社 | Flutamide preparation and its production method |
CA2318421A1 (en) * | 1998-01-14 | 1999-07-22 | Toshio Murakami | Disintegrating agent |
JP2000178182A (en) * | 1998-12-17 | 2000-06-27 | Lion Corp | Disintegrable composition |
JP2000178184A (en) * | 1998-12-17 | 2000-06-27 | Lion Corp | Granular composition, and production of tablet and granular composition |
JP2000273039A (en) * | 1999-01-20 | 2000-10-03 | Taisho Pharmaceut Co Ltd | Composition disintegrable in oral cavity |
JP2001316249A (en) * | 2000-05-11 | 2001-11-13 | Lion Corp | Tablet-type medicinal composition |
JP2002087965A (en) * | 2000-09-14 | 2002-03-27 | Lion Corp | In-mouth disintegrable aspirin-containing tablet |
AU2003235395A1 (en) * | 2002-05-22 | 2003-12-02 | Shionogi And Co., Ltd. | Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water |
-
2003
- 2003-05-21 AU AU2003235395A patent/AU2003235395A1/en not_active Abandoned
- 2003-05-21 WO PCT/JP2003/006346 patent/WO2003097102A1/en active Application Filing
- 2003-05-21 TW TW092113695A patent/TW200306868A/en unknown
- 2003-05-21 JP JP2004505098A patent/JP4743684B2/en not_active Expired - Fee Related
-
2010
- 2010-01-25 JP JP2010013649A patent/JP2010090175A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP4743684B2 (en) | 2011-08-10 |
JPWO2003097102A1 (en) | 2005-09-15 |
WO2003097102A1 (en) | 2003-11-27 |
JP2010090175A (en) | 2010-04-22 |
TW200306868A (en) | 2003-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI349664B (en) | Benzimidazole derivatives: preparation and pharmaceutical applications | |
IL173527A0 (en) | Pharmaceutical composition containing water soluble drug | |
HK1254279A1 (en) | Pharmaceutical preparation containing oxycodone and naloxone | |
IL163894A (en) | 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments | |
AU2009201465A1 (en) | Pharmaceutical Compositions with Improved Dissolution | |
HK1093508A1 (en) | Derivatives of diperdinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in preparation of drugs | |
IL173195A0 (en) | Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them | |
HK1083749A1 (en) | Solid nano pharmaceutical formulation and preparation method thereof | |
AU2003276572A1 (en) | Pharmaceutical dosage forms of biguanide-sulfonylurea combinations | |
AU2003235395A1 (en) | Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water | |
IL152900A0 (en) | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses | |
AU2003292509A1 (en) | Taste masked pharmaceutical compositions comprising bitter drug and ph sensitive polymer | |
SI1673349T1 (en) | Benzimidazole derivatives: preparation and pharmaceutical applications | |
AU2003267231A1 (en) | Pharmaceutical compositions with improved dissolution | |
AU2003207461A1 (en) | Drug mixture with enhanced dissolution rate | |
AU2003260239A1 (en) | Solid dosage forms for rapid dissolution of poorly soluble drugs | |
AU6038601A (en) | Amino acid derivatives and their use as medicines | |
IL166098A0 (en) | 3-guanindinocarbonyl-1-heteroaryl-indole derivatives preparation process their use as medicaments and pharmaceutical compositions comprising them | |
AU2002349506A1 (en) | Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions | |
IL172087A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
AU2003257982A1 (en) | Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage | |
AU2003256157A1 (en) | Oral dosage forms of water insoluble drugs and methods of making the same | |
EP1620088A4 (en) | Indole acetic acid derivatives and their use as pharmaceutical agents | |
AU2003280387A1 (en) | Pharmaceutical formulation comprising azithrocycin monohydrate | |
EP1661556A4 (en) | Medicinal preparation having improved dissolution properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |